Global X Lithium & Battery Tech ETF (LIT) Stock Price Today
Aura AI Summary
Key Stats
- $1.33BMarket Cap
- 202,444Volume
- Commodities - Metals/AgricultureSector
- $91.6252W High
- $56.3952W Low
- 59 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Global X Lithium & Battery Tech ETF (LIT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Global X Lithium & Battery Tech ETF has traded between a low of $56.39 and a high of $91.62, highlighting its annual price range. Buy and sell Global X Lithium & Battery Tech ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Most Recent News
First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.
IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...

WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age
WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...

IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy
IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.